KING LUTHER CAPITAL MANAGEMENT CORP
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 310051
FORT WORTH, TX
Position in REGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$732,462
+$730 QoQ
Shares Held
948
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026KING LUTHER CAPITAL MANAGEMENT CORP holds $9,019,114 across 6 Biotechnology names. REGN ranks #3 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
66,584 | $4,303,323 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
53,725 | $3,368,557 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
948 | $732,462 | |
| 4 | MNKD |
Mannkind Corp
|
138,605 | $339,582 | |
| 5 | ABSI |
Absci Corp
|
77,520 | $232,560 | |
| 6 | RANI |
Rani Therapeutics Holdings, Inc.
|
58,000 | $42,630 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $732,462 | 948 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $731,732 | 948 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $507,729 | 903 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $435,225 | 829 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $525,142 | 828 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $589,809 | 828 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $885,144 | 842 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $873,405 | 831 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $796,941 | 828 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $727,224 | 828 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $681,410 | 828 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $594,951 | 828 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $703,349 | 856 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $815,283 | 1,130 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $828,710 | 1,203 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,072,309 | 1,814 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,155,186 | 1,654 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,044,534 | 1,654 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,128,055 | 1,864 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,041,118 | 1,864 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $202,503 | 428 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $206,771 | 428 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $296,683 | 530 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $310,577 | 498 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||